ANDOVER, Mass., Feb. 24 /PRNewswire-FirstCall/ -- Smith & Nephew's (NYSE: SNN)(LSE:SN) Endoscopy Division today announced the launch of the DYONICS(TM) RF System, which incorporates a compact...
HAMBURG, Feb. 3 /PRNewswire-FirstCall/ -- The International Negative Pressure Wound Therapy (NPWT) Expert Panel will be hosting a global teleconference that will: -- Detail the launch of the...
ANDOVER, Mass., Feb. 1 /PRNewswire-FirstCall/ -- Smith & Nephew's (NYSE: SNN); (LSE:SN) Endoscopy Division today announced that the company has been awarded a three-year contract (effective...
MEMPHIS, Tenn., Jan. 20 /PRNewswire-FirstCall/ -- Medical device maker Smith & Nephew's (NYSE:SNN)(LSE:SN) Orthopaedics business is making available this week more than $2 million in implants...
HULL, England and FT. SASKATCHEWAN, Canada, Dec. 22 /PRNewswire-FirstCall/ -- The Advanced Wound Management division of Smith & Nephew plc (LSE:SN) ( NYSE: SNN) , announced today that its...
"Fracture putty" system to improve standard of care for injured soldiers MEMPHIS, Tenn., Nov. 20 /PRNewswire-FirstCall/ -- Smith & Nephew (NYSE: SNNNYSE:LSE:NYSE:SN) Orthopaedics Division is...
Innovative System Allows for Efficient Removal of Intrauterine Polyps and Fibroids ANDOVER, Mass., Nov. 17 /PRNewswire-FirstCall/ -- Smith & Nephew's (NYSE: SNN)(LSE:SN) Endoscopy Division...
Significant decision will benefit patients, providers ST. PETERSBURG, Fla., Nov. 9 /PRNewswire/ -- The Advanced Wound Management division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew...
MEMPHIS, Tenn., Oct. 29 /PRNewswire-FirstCall/ -- Smith & Nephew's (NYSE: SNN)(LSE:SN) Orthopaedics business announced today it has made a first-of-its-kind contribution to the Center for...
www.exogen.com - new information resource for people seeking active role in recovery RALEIGH, N.C. and DURHAM, N.C., Sept. 29 /PRNewswire-FirstCall/ -- A new website designed to help thousands of...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.155 | 0.155 | 0.155 | 0 | 0 | CS |
4 | 0 | 0 | 0.155 | 0.155 | 0.155 | 0 | 0 | CS |
12 | 0 | 0 | 0.155 | 0.155 | 0.155 | 0 | 0 | CS |
26 | 0 | 0 | 0.155 | 0.155 | 0.155 | 0 | 0 | CS |
52 | 0 | 0 | 0.155 | 0.155 | 0.155 | 0 | 0 | CS |
156 | 0 | 0 | 0.155 | 0.155 | 0.155 | 0 | 0 | CS |
260 | -0.505 | -76.5151515152 | 0.66 | 0.66 | 0.1 | 13754 | 0.24831101 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales